Shingles vaccine recommended for seniors

updated 1:04 p.m. ET May 15, 2008

WHITEHOUSE STATION, N.J. - Merck & Co. said Thursday the U.S. Centers for Disease Control and Prevention has recommended that adults 60 and over be given the company's shingles vaccine Zostavax.

The CDC's recommendation follows the unanimous recommendation of the agency's Advisory Committee on Immunization.

Shingles, also called herpes zoster, is a painful skin rash that strikes roughly one in four adults who have previously had chickenpox. According to Merck, more than 43 million Americans are at risk for shingles. However, according to a 2007 CDC survey, few adults are vaccinated against the disease.

Don't miss this on msnbc.com Health Is this even legal? Pro bono sex advice Brain food: If it helps gerbils, it could help you Why her skin was crawling with body critters How not to take a vacation from your diet Hip surgery in India? Insurance may pay

MORE FROM INFECTIOUS DISEASES

Infectious diseases Section Front

New West Nile strain may worsen epidemic Beef recall expands to 5.3 million pounds Mosquito threat multiplies after Midwest floods New global standards set for infant formula 4,000 in Denmark may have salmonella Salmonella probe frustrates top health official Laser treatment could help kill superbugs Test gives quick results for drug-resistant TB U.S. rechecking cause of salmonella outbreak Tainted tomato cases climb to 756, CDC says Infectious diseases Section Front   Add Infectious diseases headlines to your news reader: